Improvement in diagnosis of rheumatoid arthritis using dual indirect immunofluorescence and immunoblotting assays for antifilaggrin autoantibodies: A retrospective 3 year study

Journal of Rheumatology

Volumn 29, Issue 2, 2002, Pages 276-281

  Ferraro Peyret, Carole ^a   Tebib, Jacques ^a   Desbos, Agnes ^a   Bihannic, Rene ^a   Genestier, Christelle ^a   Letroublon, Marie Claude ^a   Veber, Sophie ^a   Benoit, Etienne ^a   Veysseyre Balter, Cecile ^a   Monier, Jean Claude ^a   Fabien, Nicole ^a  

^a CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

Antifilaggrin autoantibody; Immunoblotting; Rheumatoid arthritis

Indexed keywords

AUTOANTIBODY; FILAGGRIN; FILAGGRIN AUTOANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HUMAN; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; BIOLOGICAL MARKERS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNOBLOTTING; INTERMEDIATE FILAMENT PROTEINS; MIDDLE AGED; SENSITIVITY AND SPECIFICITY;

EID: 0036165138     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Demonstration of a new antinuclear antibody (antiRA33) that is highly specific for rheumatoid arthritis
2. Diagnostic value of antiRA33 antibody, antikeratin antibody, antiperinuclear factor and antinuclear antibody in early rheumatoid arthritis: Comparison with rheumatoid factor
3. A novel antigenic-antibody system specific for rheumatoid arthritis: The Sa system
4. AntiSa antibody is an accurate diagnostic and prognostic marker in adult rheumatoid arthritis
5. Detection and expression of cDNA clone that encodes a polypeptide containing two inhibitory domains of human calpastatin and its recognition by rheumatoid arthritis sera
6. Autoantibodies to calpastatin (an endogenous inhibitor of calcium dependent neutral protease, calpain) in systemic rheumatic diseases
7. Antiperinuclear factor and keratin antibodies in rheumatoid arthritis
8. The cytokeratin filament-aggregating protein filaggrin is the target of the so-called 'antikeratin antibodies' autoantibodies specific for rheumatoid arthritis
9. The antiperinuclear factor and the so-called antikeratin antibodies are the same rheumatoid arthritis-specific auto-antibodies
10. Immunoblotting detection of autoantibodies to human epidermis filaggrin: A new diagnostic test for rheumatoid arthritis
11. Diagnostic value of antibodies to filaggrin in rheumatoid arthritis
12. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
13. Autoantibodies in rheumatoid arthritis
14. An epidemiologically based follow-up study of recent arthritis. Incidence, outcome and classification
15. AntiRA 33 antinuclear autoantibodies in rheumatoid arthritis and mixed connectivitis tissue disease: Comparison with antikeratin and antiperinuclear antibodies
16. Antiperinuclear factor compared with the so-called "antikeratin" antibodies and antibodies to human epidermis filaggrin, in the diagnosis of arthritides
17. Antiperinuclear factor of the IgA isotype in active rheumatoid arthritis
18. Clinical relevance of antikeratin antibodies in rheumatoid arthritis
19. Antikeratin antibodies in rheumatoid arthritis: Frequency and correlation with other features of the disease
20. Diagnostic value of antikeratin antibodies in RA
21. Significance of antikeratin antibodies in rheumatoid arthritis
22. Antiintermediate filament antibodies, antikeratin antibody, and antiperinuclear factor in rheumatoid arthritis and infectious mononucleosis
23. Antikeratin antibodies in serum and synovial fluid show specificity for rheumatoid arthritis in a study of connective tissue diseases
24. Autoantibodies predicting the outcome of rheumatoid arthritis: Evaluation in two subsets of patients according to severity of radiographic damage
25. High diagnostic value in rheumatoid arthritis of antibodies to the stratum corneum of rat oesophagus epithelium, so-called antikeratin antibodies
26. Antikeratin antibodies: Diagnostic and prognostic markers for early rheumatoid arthritis
27. Interlaboratory variability of the antiperinuclear factor test for rheumatoid arthritis
28. Antikeratin antibodies in rheumatoid arthritis
29. Interaction of filaggrin with keratin filaments during advanced stages of normal human epidermal differentiation and in ichthyosis vulgaris
30. How useful are tests for rheumatoid factors, antiperinuclear factors, antikeratin antibody, and the HLA-DR4 antigen for the diagnosis of rheumatoid arthritis
31. Immunopathology of rheumatoid arthritis: Antikeratin antibodies precede the clinical disease
32. Antibody to stratum corneum (antikeratin antibody) and antiperinuclear factor: Markers for progressive rheumatoid arthritis
33. Antikeratin antibody and antiperinuclear factor as markers for subclinical rheumatoid disease process
34. Prospect for an additional laboratory criteria for rheumatoid arthritis
35. Prevalence of antikeratin antibodies in Greek patients with rheumatoid arthritis. A clinical, serologic, and immunogenetic study
36. Purification of filaggrin from human epidermis and measurement of antifilaggrin autoantibodies in sera from patients with rheumatoid arthritis by an enzyme-linked immunosorbent assay
37. Antifilaggrin antibodies in recent-onset arthritis
38. Evaluation of diagnostic criteria for ankylosing spondylitis: A proposal for modification of the New York criteria
39. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hand
40. The performance of the 1987 ARA classification criteria for rheumatoid arthritis in a population based cohort of patients with early inflammatory polyarthritis
41. Prevalence of selected autoantibodies in different elderly populations
42. High prevalence of anticardiolipin and other antibodies in a healthy elderly population
43. Prevalence of antikeratin antibodies in an elderly population
44. Antiperinuclear factor and antikeratin antibody: Diagnostic use in a clinical laboratory setting
45. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide
46. The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)filaggrin by deimination of arginine residues
47. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis - Specific autoantibodies
48. The prognostic value of the antiperinuclear factor, anticitrullinated peptide antibodies and rheumatoid factor in early rheumatoid arthritis
49. The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the a and β chains of fibrin
50. Association of autoantibodies to filaggrin with an active disease in early rheumatoid arthritis